Related Experiment Videos
Pathogenesis of osteoporosis
Lawrence G Raisz1, Gideon A Rodan
1Division of Endocrinology and Metabolism, Department of Medicine, University of Connecticut Health Center, 263 Farmington Avenue, MC 1850, Farmington, CT 06030-1850, USA. raisznso.uchc.edu
Abstract:
There are many pathways that might lead to decreased bone mass, skeletal fragility, and increased fracture risk in osteoporosis. Some of these have been clearly identified, such as estrogen deficiency. Others that were conceived on the basis of experimental findings and recent scientific discoveries such as abnormalities of cytokines, bone growth factors, and osteoblast transcription factors remain interesting but speculative. The recent revolution in genomics and proteomics opens new avenues for pursuing in great depth the pathways leading to osteoporosis. Animal models developed largely in rodents can suggest specific factors that can be further studied in primate models and in osteoporotic patients. Identification of specific pathogenetic mechanisms should lead to new approaches to the diagnosis and management of this disorder.
Insights
Osteoporosis involves complex pathways affecting bone mass and fracture risk. Research using genomics and proteomics aims to identify new mechanisms for better diagnosis and treatment.
Area of Science:
- Bone biology and osteoporosis research.
Background:
- Osteoporosis is characterized by decreased bone mass, skeletal fragility, and increased fracture risk.
- Established causes include estrogen deficiency, while others like cytokine and growth factor abnormalities are speculative.
Purpose of the Study:
- To explore diverse pathogenetic mechanisms contributing to osteoporosis.
- To leverage advancements in genomics and proteomics for in-depth investigation of osteoporosis pathways.
Main Methods:
- Review of established and speculative pathways in osteoporosis.
- Utilizing insights from genomics and proteomics.
- Employing animal models (rodents, primates) for studying pathogenetic factors.
Main Results:
- Identified estrogen deficiency as a key factor.
- Highlighted speculative roles of cytokines, bone growth factors, and osteoblast transcription factors.
- Genomics and proteomics offer new research avenues.
Conclusions:
- Understanding diverse pathogenetic mechanisms is crucial for osteoporosis.
- Animal models aid in identifying factors for human studies.
- Identifying specific mechanisms will advance osteoporosis diagnosis and management.
Related Concept Videos
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:17Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:40Bone Remodeling
01:31Osteoclasts in Bone Remodeling
01:02What is the Skeletal System?
01:31Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...